Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

Volume: 48, Issue: 2, Pages: 103 - 114
Published: Feb 1, 2018
Abstract
Chemotherapy is one of the most important treatment modalities for advanced hepatocellular carcinoma (HCC). On the basis of the results of two pivotal Phase III placebo-controlled studies, sorafenib is currently acknowledged worldwide as the standard therapeutic agent for advanced HCC. Following the introduction of sorafenib for the treatment of HCC, Phase III trials of numerous other agents as first-line or second-line chemotherapy have been...
Paper Details
Title
Chemotherapy for hepatocellular carcinoma: current status and future perspectives.
Published Date
Feb 1, 2018
Volume
48
Issue
2
Pages
103 - 114
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.